EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4

Trent D Ashton iD, Petar P S Calic iD, Madeline G Dans iD, Zi Kang Ooi, Qingmiao Zhou, Katie Loi iD, Kate E Jarman iD, Josephine Palandri, Deyun Qiu iD, Adele M Lehane iD, Bikash Maity, Nirupam De und 12 weitere

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Trent D Ashton und 23 weiteren Autor:innen. Beteiligte Einrichtung: Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Victoria, Australia. Hauptthemen laut MEDLINE: Antimalarials, Quinazolinones, Plasmodium falciparum. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council of Australia, Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS B.E.S., Medicines for Malaria Venture.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of resistance against current antimalarial treatments has necessitated the need for the development of novel antimalarial chemotypes. Toward this goal, we recently optimised the antimalarial activity of the dihydroquinazolinone scaffold and showed it targeted PfATP4. Here, we deconstruct the lactam moiety of the tricyclic dihydroquinazolinone scaffold and investigate the structure‐activity relationship of the truncated scaffold. It was shown that SAR between scaffolds was largely transferrable and generated analogues with potent asexual stage activity. Evaluation of the truncated analogues against PfATP4 mutant drug‐resistant parasite strains and in assays measuring PfATP4‐associated ATPase activity demonstrated retention of PfATP4 as the molecular target. Analogues exhibited activity against both male and female gametes and multidrug resistant parasites. Limited efficacy of analogues in a P. berghei asexual stage mouse model was attributed to their moderate metabolic stability and low aqueous stability. Further development is required to address these attributes toward the potential use of the dihydroquinazolinone class in a curative and transmission blocking combination antimalarial therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsQuinazolinonesPlasmodium falciparumStructure-Activity RelationshipAnimalsMiceLactamsMolecular StructurePlasmodium bergheiFemaleDose-Response Relationship, DrugParasitic Sensitivity TestsMalariaMaleHumans

Stichwörter der Autor:innen

AntimalarialMalariaPfATP4PlasmodiumQuinazolinone

Substanzen

AntimalarialsQuinazolinonesLactams

Autor:innen und Institutionen

  • Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Victoria, Australia.
  • Department of Medical Biology, University of Melbourne, Parkville, 3010, Victoria, Australia.
  • Research School of Biology, Australian National University, Canberra, 2601, Australia.
  • TCG Lifesciences, Kolkata, West Bengal, 700091, India.
  • Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK.
  • Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide, 5005, Australia.

ORCID-Profile: Trent D Ashton, Petar P S Calic, Madeline G Dans, Katie Loi, Kate E Jarman, Deyun Qiu, Adele M Lehane, Mufuliat T Famodimu, Emma Y Mao, Maria R Gancheva, Danny W Wilson, Alan F Cowman, Brad E Sleebs

Förderung

  • National Health and Medical Research Council of Australia
  • Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS B.E.S.
  • Medicines for Malaria Venture
  • Medical Research Council Career Development Award
  • MMV grant
  • Australian Red Cross Lifeblood
  • Walter and Eliza Hall Institute
  • Alan Harris Scholarship

Zitieren

APA

Ashton, T. D., Calic, P. P. S., Dans, M. G., Kang Ooi, Z., Zhou, Q., Loi, K., Jarman, K. E., Palandri, J., Qiu, D., Lehane, A. M., Maity, B., De, N., Famodimu, M. T., Delves, M. J., Mao, E. Y., Gancheva, M. R., Wilson, D. W., Chowdury, M., de Koning-Ward, T. F., …, & Sleebs, B. E. (2024). Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4. ChemMedChem. https://doi.org/10.1002/cmdc.202400549

Vancouver

Ashton TD, Calic PPS, Dans MG, Kang Ooi Z, Zhou Q, Loi K, et al. Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4. ChemMedChem. 2024. doi:10.1002/cmdc.202400549

BibTeX
@article{Ashton2024,
  author = {Ashton, Trent D and Calic, Petar P S and Dans, Madeline G and Kang Ooi, Zi and Zhou, Qingmiao and Loi, Katie and Jarman, Kate E and Palandri, Josephine and Qiu, Deyun and Lehane, Adele M and Maity, Bikash and De, Nirupam and Famodimu, Mufuliat T and Delves, Michael J and Mao, Emma Y and Gancheva, Maria R and Wilson, Danny W and Chowdury, Mrittika and de Koning-Ward, Tania F and Baud, Delphine and Brand, Stephen and Jackson, Paul F and Cowman, Alan F and Sleebs, Brad E},
  title = {Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400549}
}
Kostenlos starten →